The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules

Clinical trial NCT03638076 · COMPLETED

Trial details

NCT number: NCT03638076
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2017-07-26
Primary completion: 2018-11-22
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.